what is known already: Although IVF is generally safe and successful for the treatment of human infertility, there is increasing evidence that those conceived by IVF suffer increased health risks. The mitochondrion is a multifunctional organelle that plays a crucial role in early development. We hypothesized that mitochondrial dysfunction is associated with increased IVF-induced embryonic defects and risks in offspring. study design, size, duration: After either IVF and development (IVO groups as control) or IVF and culture (IVF groups), blastocysts were collected and transferred to pseudo-pregnant recipient mice. Both IVO and IVF embryos were sampled at E3.5, E7.5 and E10.5, and the expression profiles of mitochondria-related genes from the pre-to post-implantation stage were compared.
Introduction
In vitro fertilization (IVF) is generally safe and successful for the treatment of infertility humans and for animal propagation. However, there are associated small, but worrying, safety concerns. These include embryonic loss (Racowsky, 2002) , preterm birth and perinatal mortality (Bergh et al., 1999) , lower birthweight and birth defects (Schieve et al., 2002; Wen et al., 2012; Hansen et al., 2013) , and increased risk of childhood and adulthood diseases (Klemetti et al., 2006; Ceelen et al., 2008; Reefhuis et al., 2009) . While these adverse outcomes are thought to be due to the IVF manipulation and culture process, the precise mechanisms remain largely unclear.
Recent studies have compared the gene and protein expression profiles of in vivo (IVO) and in vitro fertilized (IVF) embryos in mice (Giritharan et al., 2007; Fernandez-Gonzalez et al., 2009; Nie et al., 2013; Tan et al., 2015) , cattle (Driver et al., 2012) and pigs (Miles et al., 2008; Bauer et al., 2010) . These studies suggest that both the fertilization procedure itself and the subsequent culture methods used in IVF may disrupt biological processes, including genetic information processing (such as transcription, translation and post-transcriptional regulation), energy and amino acid metabolism, and cytoskeletal organization. IVF may also affect mitochondrial function, which in turn could affect embryonic development. Indeed, our recently published studies in mice (Nie et al., 2013; Sui et al., 2014) , together with other animal studies (Tamassia et al., 2004; Thouas et al., 2004; Suzuki et al., 2006) , indicate that mitochondrial dysfunctions are highly associated with compromised in vitro embryonic development. In humans, evidence from unfertilized oocytes and poor quality embryos following IVF also suggests that mitochondrial dysfunction adversely affects the outcome of IVF treatment (Vanblerkom et al., 1995; Lee et al., 2000; Hsieh et al., 2002 Hsieh et al., , 2004 .
Mitochondria are the most abundant and conspicuous organelle in the early embryo. The preimplantation embryo has high energy needs. During development, embryonic metabolism changes from predominantly glycolytic early on to predominantly aerobic oxidative phosphorylation (OXPHOS). Concomitant with this transition, mitochondrial ultrastructure and morphology also changes, with the development of cristae, a denser matrix, and an elongated or branched appearance (Schatten et al., 2014) . Well-organized mitochondrial biogenesis and function have previously been shown to be important for early embryonic development (Dumollard et al., 2007; Ramalho-Santos et al., 2009) . Therefore, it is not surprising that high-throughput analyses have shown that the dynamic fine-tuning of mitochondria-related gene expression is extremely critical for early embryonic development (Zeng et al., 2004; Xue et al., 2013) .
Due to the importance of mitochondria-related genes in the early embryo, knockout or targeted mutations that disrupt mitochondrial biogenesis or function can lead to retarded embryonic growth or may even be lethal during the peri-or post-implantation stage (Huo and Scarpulla, 2001; Agostino et al., 2003; Hance et al., 2005; Lindhurst et al., 2006; Humble et al., 2013) . Furthermore, based on the 'fetal origins of adult disease' hypothesis proposed by Barker and Osmond (1986) , fetal development may predispose offspring to a range of diseases in childhood and adulthood. Indeed, mitochondrial dysfunction during embryonic and fetal development is implicated in metabolic and neurological disease (Lee et al., 2005; Mortensen et al., 2014) .
Considering that mitochondrial dysfunction contributes to impaired embryonic development and may lead to future diseases, it is important to explore the mechanisms of IVF-induced mitochondrial dysfunction. Many genes participate in mitochondrial biogenesis and function. In addition to the 13 mitochondrial DNA (mtDNA) encoded proteins, it is estimated that there are 1200 proteins encoded by nuclear DNA (nDNA) which can enter the mouse mitochondrial matrix or bind to its membrane (Mootha et al., 2003) . The gene set encoding these mitochondria-related proteins has been used for gene expression analysis to evaluate the involvement of mitochondrial dysfunctions in cardiac pathology (Jian et al., 2010 (Jian et al., , 2011 and cancer pathology (Hsiao et al., 2013 (Hsiao et al., , 2014 .
Our previous proteomic study suggested that IVF-induced mitochondrial dysfunction may contribute to impaired early embryonic development (Nie et al., 2013) . In the present study, we used a mitochondria-related gene set to filter the transcriptomes of IVO and IVF embryos from embryonic day 3.5 (E3.5) to E10.5. We then compared the mitochondriarelated gene expression profiles between IVO and IVF embryos. Targeted profiling of mitochondria-related genes leads to a more efficient enrichment of involved mitochondrial functions when compared with a global gene expression analysis. In addition, to the best of our knowledge, this is the first dynamic transcriptome analysis of IVF embryos from the pre-to post-implantation stage.
Materials and Methods

Animal preparation
F1 female mice (ICR, 5 -6 weeks) and F1 male mice (ICR, 8 -9 weeks) were fed ad libitum and housed in a room with a controlled light cycle (12L:12D). All studies adhered to procedures that are consistent with the China Agricultural University Guide for the Care and Use of Laboratory Animals. Females were superovulated by an i.p. injection of 5 IU pregnant mare serum gonadotrophin (PMSG; Ningbo Hormone Product Co., Ltd, Ningbo, China), followed 48 h later by an i.p. injection of 5 IU human chorionic gonadotrophin (hCG; Ningbo Hormone Product Co., Ltd). In the IVO groups, F1 females were naturally mated with F1 males after the hCG injection.
Experimental design
A well-established experimental design (Li et al., 2005; Giritharan et al., 2007;  Delle Piane et al., 2010; Fauque et al., 2010a,b) was adopted to test the effect of the IVF process on the mitochondria-related gene expression profiles of early embryos. In this experiment design, the IVF process, which includes IVF and culture, was adopted as an integrated technical treatment. As illustrated in Fig. 1A , all female mice were superovulated and randomly divided into the two groups (IVO or IVF). After either IVFand development (IVO control group) or IVF and culture (IVF group), blastocysts were collected and transferred to pseudo-pregnant recipient mice. In vivo fertilized blastocysts (at E3.5) were collected by flushing each uterus of the plugged females using HEPES-buffered medium 2 (M2; Sigma-Aldrich, St Louis, MO, USA). The selection of blastocysts in both groups was based on the developmental progress and morphology. In detail, well-developed latecavitating blastocysts were collected at 96 -100 and 106 -112 h post-hCG for the IVO and IVF groups, respectively, according to previous descriptions about the developmental progress of IVO and IVF blastocysts (Giritharan et al., 2007) . At E7.5, E10.5, recipient females were sacrificed, and conceptuses with normal morphology, which were more likely to establish a successful pregnancy, were collected from the uterus of recipients (Nie et al., 2013; Sui et al., 2014) . Similar to previous studies (Fauque et al., 2010a,b) , ovulation induction and embryo transfer were performed in both the IVO and IVF groups to exclude the effects of these processes on the quality of oocytes and embryos. These processes were carried out according to a standard and well-accepted procedure (Nagy et al., 2003) . All technical procedures were performed by skilled technicians under strictly controlled conditions and optimized environments.
Due to the small amount of RNA in each early embryo, and the limited source of IVF embryos, a single pooling strategy was used, as described previously (Huang and Khatib, 2010; Fauque et al., 2010a; Driver et al., 2012) . This pooling strategy is appropriate in experiments with low sample yields, and could reduce biological variance, thus increasing the power to detect changes (Karp et al., 2005) . Moreover, as IVF-induced disorders always display population characteristics, single pooling is a rational strategy to ensure a relatively large sample size, which was critical for our study to ensure that the pooled sample was representative of the population.
IVF and embryo culture
At 14 h post-hCG treatment, cumulus-enclosed oocyte complexes were recovered from oviducts and cumulus cells were removed by digestion with hyaluronidase (Sigma-Aldrich) for 3 -5 min. The oocytes were rinsed in human tubal fluid (HTF) medium (Sage, Bedminster, NJ, USA), and placed into 60 ml drops of HTF medium covered with paraffin oil, before being equilibrated overnight in an incubator at 378C and 5% CO 2 . Sperm was collected from the cauda epididymis and capacitated for 1 h in HTF medium at 378C and 5% CO 2 . Oocytes were inseminated with 10 6 spermatozoa. Four hours after the insemination, the oocytes/zygotes were washed several times in potassium simplex optimization medium containing amino acids (KSOM + AA; Millipore, Billerica, MA, USA), and then transferred to 60 ml drops of KSOM medium. The zygotes, as determined by the presence of two pronuclei, were cultured to the blastocyst stage at 378C in a 5% CO 2 atmosphere.
Blastocyst collection and embryo transfer
In the IVO groups, blastocysts were obtained from donor females by flushing the uterus with M2 medium. The criteria for collecting blastocysts for embryo transfer were based on the developmental progress and morphology. According to previous reports, in vitro embryos show delayed preimplantation development (Giritharan et al., 2007; Rivera et al., 2008; Fernandez-Gonzalez et al., 2009) . Our study design was based on the work of Giritharan et al. (2007) ; in order to obtain blastocysts of identical morphology, we collected IVF blastocysts at 106-112 h post-hCG after culturing in KSOM medium, while control IVO blastocysts were collected at 96-100 h post-hCG. Welldeveloped late-cavitating blastocysts of similar morphology were sampled for further analysis or selected for embryo transfer in each group. Pseudopregnant female mice were mated to vasectomized males 3.5 days prior to embryo transfer. Twelve blastocysts from the IVO or IVF group were transferred to a single recipient, respectively, with six embryos in each uterine horn. The implantation sites at E6.5 and E7.5 were determined by intravenous injection of 0.1 ml of 1% (w/v) Chicago blue dye (Sigma, St Louis, MO, USA) in saline, the recipients being sacrificed 5 min later.
Collection and morphometric analysis of post-implantation embryos
The criteria for selecting embryos for pooling were based on morphology.
Embryos showing typical morphological features according to the wellestablished landmarks (Theiler, 1989; Downs and Davies, 1993) were selected for pooling. In detail, at E7.5, well-developed embryos at the gastrulation stage were characterized by a sealed-off amniotic cavity and the formation of three distinct cavities (amniotic cavity, exocoelom and ectoplacetal cleft). At E10.5, a definitive placenta was formed, and the well-developed embryos were characterized by deepening of the lens pit and the appearance of the physiological umbilical hernia. We also performed morphometric analysis at E13.5. Fetuses showed indented distal borders of the anterior and posterior footplates, and the pinna was well defined. In addition, somites were clearly visible at this stage in the distal part of the tail. At E7.5, the conceptuses covered with the decidual mass were gently teased away from the uterus, the decidua in which the conceptus embedded was peeled off, and the parietal yolk sac was opened to expose the visceral yolk sac endoderm layer. The epiblast was separated from the extraembryonic tissues using microdissecting watchmaker's forceps under a stereomicroscope. At E10.5, embryos were collected after removing the placenta and amnion. All sampled embryos for RNA isolation were serially washed with phosphate-buffered saline (PBS, GIBCO, Life Technologies, NY, USA) and stored immediately in liquid nitrogen for further use. At E13.5, fetuses within their parietal and visceral yolk sac with intact placentas were dissected from their visceral yolk sac after removal of the parietal yolk sac. The sampled embryos/fetuses for morphometric analysis were placed in PBS and imaged using a stereomicroscope (SZX16; Olympus, Tokyo, Japan) equipped with a digital camera (E620; Olympus).
In addition, to avoid cross-contamination between embryonic and extraembryonic tissues, we controlled the dissection by detecting the expression of markers specific to the extraembryonic ectoderm (ETS-related transcription factor, Elf5), ectoplacental cone (Achaete-scute like 2, ASCL2, also known as Mash2) and epiblast (fibroblast growth factor 5, Fgf5) at E7.5 (Sui et al., 2014) .
High-throughput RNA sequencing and biological analysis
Total RNAs were extracted from embryos at different stages with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Polyadenylated RNAs were isolated using the Oligotex mRNA Midi Kit (Qiagen, Valencia, CA, USA). The RNA sequencing libraries were constructed using the SOLiD Whole Transcriptome Analysis Kit following the standard protocol (AB, Applied Biosystems, USA) and sequenced on the Applied Biosystems SOLiD platform to generate high-quality single-end reads. The raw reads were aligned to genome sequences, trimming off a nucleotide each from the 5 ′ and 3 ′ ends and allowing up to two mismatches. Reads mapped to multiple locations were discarded and only uniquely mapped reads were used for the subsequent analysis. Gene expression levels were measured in reads per kilobase of exon model per million mapped reads (RPKM).
To increase the power to detect biologically meaningful functions, a relative relaxed criterion of fold change (2-fold) and P-value (,0.05) was used to filter differentially expressed mitochondria-related genes (DEMGs) for biological analysis.
The 
Measurement of reactive oxygen species and glutathione
Intracellular reactive oxygen species (ROS) were detected by oxidationsensitive fluorescent probe (DCFH-DA; Beyotime, Jiangsu, China). Ten blastocysts from each group were incubated in the dark in 10 mM DCFH-DA diluted with M2 for 20 min at 378C, according to the manufacturer's instructions. Blastocysts were then washed three times with PBS containing 0.1% (w/v) polyvinyl alcohol (PVA). DCFH-DA was deacetylated intracellularly by non-specific esterase, which was further oxidized by ROS to the fluorescent compound 2,7-dichlorofluorescein (DCF). DCF fluorescence signals were detected using an inverted epifluorescence microscope (IX71; Olympus).
Contents of intracellular reduced glutathione (GSH) and oxidized glutathione (GSSG) in each blastocyst were determined using commercially available kits (Beyotime), according to the manufacturer's instructions. Absorbance was read at 412 nm using the microplate reader (Infinite M200 PRO; NanoQuant, Tecan, Switzerland). Approximately 20 -50 blastocysts were used for each batch and all detection experiments were repeated at least three times.
Apoptosis analysis
At the blastocyst stage, the embryos were washed three times with 0.1% (w/v) PVA/PBS and then transferred to PBS supplemented with 4% (w/v) paraformaldehyde and 0.5% (v/v) Triton X-100 for simultaneous fixation and permeabilization at 378C for 45 min. Apoptotic nuclei were detected by terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) assay using the In Situ Cell Death Detection Kit (Roche, Boehringer Mannheim, Germany). According to the manufacturer's instructions, fixed embryos were incubated in the TUNEL reaction medium for 1 h at 378C in the dark. After the reaction was stopped, the embryos were washed, transferred into a 2 mg/ml DAPI (4 ′ , 6-diamidine-2 ′ -penylindole dihydrochloride; Vector Laboratories Inc., Burlingame, CA, USA) solution, and mounted on slides. The number of apoptotic nuclei and total number of nuclei were determined under an epifluorescence microscope (BX51; Olympus).
RNA isolation and quantitative real-time RT-PCR
The total RNA extraction from the embryos at the blastocyst, E7.5 and E10.5 stages was performed using TRIzol (Invitrogen) according to the manufacturer's instructions. Before reverse transcription (RT), RNA samples were digested with DNase I (Fermentas, Hanover, MD, USA) to remove contaminating genomic DNA. The concentration and the quality of the extracted total RNA were assessed by the A 260 nm/A 280 nm and A 260 nm/A 230 nm ratios determined using a DS-11 spectrophotometer (Denovix, Wilmington, NC, USA). RT was accomplished by using the commercially available first-strand cDNA synthesis kit (iScript cDNA Synthesis Kit, Bio-Rad Laboratories, USA). The real-time PCR was performed in a Bio-Rad CFX96 Real-Time PCR System using SsoFast EvaGreen Supermix (Bio-Rad Laboratories). Related primer information is summarized in Supplementary Data, Table SI .
MtDNA copy number quantification by qPCR
The nuclear-encoded b-actin gene and the mitochondria-encoded NADH dehydrogenase subunit 5 gene (MT-ND5) were used to determine the nDNA and mtDNA copy numbers, respectively. Both the b-actin gene and MT-ND5 gene were amplified by PCR. The PCR products were extracted using the Tiangen gel extraction kit (Tiangen Biotech, Beijing, China), and cloned into the pEASYTM-T5 Zero Cloning vector (TransGen Biotech). Standard curves were determined using recombinant plasmids, which were serially diluted by 10 3 -10 8 times. For each sample, the mtDNA and nDNA copy numbers are calculated using the threshold cycle number (CT) and corrected from the standard curve. The overall number of mtDNA copies per cell was calculated using the following formula: mtDNA copies per cell ¼ MT-ND5 copy number/(b-actin copy number/2).
Methylated DNA immunoprecipitation-sequencing
Global genomic DNA, including both nDNA and mtDNA, was isolated from embryo samples using Qiagen DNeasy kits (Qiagen), according to the manufacturer's instructions. The quality of each DNA sample was analyzed for integrity, purity and concentration on a Nanodrop Spectrophotometer DN-1000 (Nanodrop Technologies, Wilmington, DE, USA). Genomic DNA was then fragmented using a Covarias sonication system (Covarias, Woburn, MA, USA). After sonication, the fragments were denatured to produce single-stranded DNA (ssDNA). Following denaturation, the ssDNA was incubated with monoclonal 5-methyl-cytidine (5mC) antibodies. Magnetic beads conjugated to anti-mouse-IgG were then used to bind the anti-5mC antibodies, and unbound DNA was removed along with the supernatant. Finally, proteinase K was used to digest the antibodies, and the DNA was released and collected. Sequencing was carried out on the Illumina Hiseq 2000 (Illumina, San Diego, CA, USA) following the standard protocol to generate paired-end 50 bp reads by a commercial company (BGI, Shenzhen, Guangdong, China).
Methylated DNA immunoprecipitation-quantitative real-time PCR
Global genomic DNA, including both nDNA and mtDNA, was isolated from mouse early embryos using the Solar MicroElute Genomic DNA Kit (Solar Technologies Inc., Gaithersburg, MD, USA), according to the manufacturer's protocol. The sonicated DNA was treated with the EpiQuik MeDIP Ultra kit (Epigentek, NY, USA) to enrich the methylated DNA according to the manufacturer's protocol. Briefly, 2 mg of DNA was sheared by sonication on ice until the size of most DNA fragments ranged between 100 and 600 bp (15 cycles of 30 s on and 30 s off at high power using Diagenode Bioruptor Plus). Samples were then 5-methyl-CpG-immunoprecipitated according to the Epigentek manual. Substitution of IgG for the antibody (supplied in the kit) against methylated DNA served as a negative control. The enriched methylated DNA was measured by qPCR with specific primers. To validate the specificity and efficiency of our MeDIP experiment, qPCR was performed with control unmethylated DNA and methylated DNA supplied in the kit. The cycle threshold (CT) value of each sample was normalized to the input DNA fraction CT value to account for DNA sample preparation differences, and then enrichment efficiency of methylated DNA immunoprecipitation-quantitative real-time PCR (MeDIP-qPCR) was measured as fold enrichment (FE) using the following formula: FE (%) ¼ 2 (IgG CT -Normalized sample CT) × 100%. Related primer information is summarized in Supplementary Data, Table SI .
Results
General profiling of DEMGs between IVO and IVF embryos
At E3.5, E7.5 and E10.5, 37 271, 822 and 324 embryos in the IVO groups and 38 394, 795 and 278 embryos in the IVF groups were sampled, respectively. Using the transcriptomic data from the IVO and IVF embryos, we filtered out 1166, 1134 and 1153 mitochondria-related genes at E3.5, E7.5 and E10.5, respectively. At E3.5, we found that 806 mitochondria-related genes were significantly altered in IVF blastocysts (P , 0.05), which accounted for 69.13% of identified mitochondria-related genes. At E7.5 and E10.5, 795 and 753 mitochondria-related genes were significantly changed in IVF embryos (P , 0.05), which accounted for 70.11 and 65.31% of identified mitochondria-related genes, respectively. The proportion of differentially expressed genes for mitochondria-related genes was higher than that for the global transcriptome (Supplementary data, Fig. S1A ), suggesting that mitochondria-related genes may contribute largely to IVFinduced embryonic defects. Most DEMGs showed only mild changes (P , 0.05, fold change , 2 or .0.5), accounting for 84.73, 79.75 and 83.93% of total DEMGs at E3.5, E7.5 and E10.5, respectively. More DEMGs were up-regulated at E3.5 and more DEMGs were down-regulated at E7.5 and E10.5. Therefore, the DEMG patterns in IVF embryos were highly variable at the different time points (Fig. 1B) .
Dynamic analysis showed that from E3.5 to E10.5, many DEMGs showed consistent up-regulation or down-regulation in IVF embryos compared with IVO embryos. Up-regulated DEMGs are functionally associated with the electron transport chain, OXPHOS, oxoacid metabolic process, amino acid metabolism and transmembrane transport ( Fig. 2A) . Down-regulated DEMGs are involved in amino acid metabolism, response to ROS and apoptosis (Fig. 2B ). As these DEMGs were dysregulated throughout the pre-to post-implantation stage, they may contribute to the consistently abnormal development of IVF embryos.
Functional profiling of DEMGs between the IVO and IVF groups
In keeping with the results from our previous proteomic studies (Nie et al., 2013; Sui et al., 2014) , functional profiling of the global transcriptome also indicates that mitochondrial dysfunction plays a crucial role in IVF-induced embryonic defects. Both GO and KEGG analyses showed that many biological processes and pathways associated with mitochondrial functions, such as 'primary metabolic processes', 'response to ROS', 'electron transport chain', 'fatty acid metabolic process' and 'apoptotic mitochondrial change', were dysregulated (Supplementary Data, Fig. S1B and Table SII) . GO classification of the DEMGs (fold change .2; P , 0.05) (Supplementary Data, Tables SIII -SV) of the IVO and IVF embryos at each time point (Fig. 2C ) with high-resolution profiling, highlighted mitochondria-related genes. Cluster analysis of biological processes showed that mitochondrial dysfunction in IVF embryos is generally associated with 'oxoacid metabolic process', 'response to ROS', 'apoptosis', 'transmembrane transport' and 'electron transport chain'. At each time point, the IVF embryos showed a unique pattern of GO annotation. At E3.5, most DEMGs (84%) enriched in 'oxoacid metabolic process' term were significantly up-regulated in IVF embryos. However, most DEMGs (92%) enriched in 'oxoacid metabolism' term were down-regulated in IVF embryos at E7.5. Similarly, more genes enriched in 'apoptosis' were up-regulated in IVF blastocysts, but were generally down-regulated in IVF embryos at E7.5. The functional variability suggest that IVF-induced mitochondrial dysfunction during early embryonic development is complex.
We next performed KEGG pathway analysis to identify the significantly enriched pathways (P , 0.05) at each time point (Table I) . Fatty acid and amino acid metabolism pathways were significantly enriched from the pre-to post-implantation stage. Also, many pathways of human neurodegenerative diseases (NDs), including 'Alzheimer's disease (AD)', 'Parkinson's disease (PD)' and 'Huntington's disease (HD)', were consistently highlighted. Detailed analysis showed that the DEMGs in these disease pathways are involved in OXPHOS and apoptosis, which is highly associated with pathology of NDs.
Using DEMGs as seed nodes, interaction networks of DEMGs were constructed at each time point (Fig. 3 and Supplementary Data, Figs SII -SIV). In addition to functional clusters similar to those identified by GO and KEGG pathway analysis, other processes, such as hormone synthesis (prostaglandin synthesis at E7.5 and steroid metabolism at E10.5) and genetic information processing (mitochondrial protein synthesis at E7.5 and E10.5, and mitochondrial biogenesis and mtDNA replication at E10.5), were clustered during the post-implantation stage.
The MGI analysis showed that many DEMGs were annotated with phenotypes associated with aberrant embryonic/fetal development (Supplementary data, Tables SVI-SVIII), such as 'decreased embryo size', 'embryonic growth retardation', 'embryonic growth arrest', 'abnormal embryo implantation', 'complete embryonic lethality between implantation and somite formation' and 'partial lethality throughout fetal growth and development'. Interestingly, we observed that many of these genes were also annotated with terms such as 'abnormal neural tube morphology/ development', 'decreased neuron/neuronal precursor cell number', 'neurodegeneration' and 'increased neuron apoptosis'. This analysis implied that mitochondrial dysfunctions were not only involved in the delayed embryonic development or embryonic lethality observed in IVF embryos, but also are related to impaired fetal neural development.
Impaired mtDNA replication and mitochondrial biogenesis in IVF embryos
Based on the above-mentioned functional profiling, we identified many DEMGs that are functionally associated with mtDNA replication and mitochondrial biogenesis during the post-implantation stage (Fig. 4A) . Interaction network analysis indicated that a small category of wellknown genes essential for mtDNA replication, including single-stranded DNA binding protein 1 (Ssbp1) and mtDNA polymerase subunit gamma-2 (Polg2), were tightly clustered at E10.5. Both of these genes were down-regulated at E10.5.
At E7.5, GO analysis indicated that many DEMGs enriched in 'regulation of system process' could be responsible for the mitochondrial biogenesis. These DEMGs included dopamine receptor D2 (Drd2), annexin A6 (Anxa6), adrenergic receptor, beta 2 (Adrb2), nitric oxide synthase 1, neuronal (Nos1), caveolin 1, caveolae protein (Cav1), leptin (Lep) and RAB3A, member RAS oncogene family (Rab3a) (Fig. 4A) .
In addition, at both E7.5 and E10.5, interaction networks indicated disorganized 'mitochondrial protein synthesis', which is critical for mitochondrial biogenesis (Sylvester et al., 2004; Battersby and Richter, 2013) . Both mitochondrial ribosomal proteins (MRPs) (Mrpl1, Mrpl15, Mrps18c, Mrps10, Mrpl13, Mrpl33, etc.) and mitochondrial-specific translation elongation factors (Tufm, Gfm2) were dysregulated in IVF embryos. From these findings, we hypothesized that mtDNA replication and mitochondrial biogenesis are depressed in IVF post-implantation embryos. Quantitative analysis of mtDNA copy number from single embryos showed that IVF embryos are generally characterized by lower mtDNA copy number (Fig. 4B) . This result agreed with the inhibited expression of Polg2 and Ssbp1 in IVF post-implantation embryos ( Fig. 4C and D) . Furthermore, we demonstrated that melatonin, a mitochondria-targeted antioxidant, could alleviate the depressed mtDNA replication in IVF embryos (Fig. 4B ). In addition, the inhibited expression of Polg2 and Ssbp1 could also be reversed in melatonin-treated IVF (IVF-MT) post-implantation embryos ( Fig. 4C and D) .
Impaired DNA methylation maintenance of mitochondria-related genes in IVF embryos
We found consistently inhibited expression of DNA methyltransferase 1 (Dnmt1) from E7.5 to E10.5, which was validated at E10.5 by quantitative real-time RT -PCR (qRT -PCR) (Fig. 5A) . As Dnmt1 maintains global DNA methylation levels, this observation was reminiscent of impaired DNA methylation maintenance of mitochondria-related genes. To test this, the methylation levels of nDNA-encoded mitochondrial genes (Supplementary data, Table SIX) , as well as mtDNA-encoded mitochondrial genes (Supplementary data, Table SX ) of IVO and IVF postimplantation embryos, were compared separately. In the promoter region of nDNA-encoded mitochondrial genes, we observed evident hypomethylation in IVF embryos at both E7.5 and E10.5 (Fig. 5B) . Comparative analysis of mtDNA-encoded mitochondrial genes methylation levels showed generally similar enrichment patterns between IVO and IVF embryos. However, we also observed a slight hypomethylation in the mtDNA-encoded NADH dehydrogenase subunit-2 (MT-ND2) in IVF embryos (Fig. 5C ). Furthermore, we performed MeDIP-qPCR analysis, the results of which agreed with this observation (Fig. 5D ).
To test if the changed methylation levels are associated with altered expression levels of mitochondria-related genes, we conducted a correlation analysis between promoter DNA methylation and expression levels of mitochondria-related genes in each group. The results showed that for both nDNA-encoded mitochondrial genes (Fig. 5E ) and an mtDNA-encoded mitochondrial gene (i.e. MT-ND2) (Fig. 5F ), the DNA methylation levels negatively correlated with gene expression levels.
Dysregulated glutathione/glutathione peroxidase (GSH/GPx) system and apoptosis in IVF embryos
Based on GO analysis, IVF preimplantation embryos displayed an aberrant 'response to ROS' process, which is functionally associated with mitochondria-mediated apoptosis (Fig. 6A) . In particular, our data implied a dysregulated GSH/GPx system in IVF embryos (Fig. 6B) . Certain key genes responsible for the GSH/GPx system, including glutamate-cysteine ligase, catalytic subunit (Gclc), glutamate-ammonia ligase (Glul) and glutathione peroxidase (Gpx4), showed consistent down-regulation or up-regulation from E3.5 to E10.5 (Fig. 6C) . For Gclc and Glul, this observation was further validated by qRT-PCR, especially during the post-implantation period (Fig. 6D) . These results led us to hypothesize that GSH synthesis is depressed in IVF embryos. Quantitative detection of GSH showed that the GSH content in each IVF blastocyst was significantly lower than that in the IVO blastocyst (Fig. 6E) . GSH is a crucial antioxidant that can be endogenously produced by embryos as early as the blastocyst stage. Therefore, the decreased GSH content in IVF blastocysts may lead to increased accumulation of ROS. This possibility was confirmed by a test of the ROS levels, showed higher ROS levels in IVF embryos compared with those in IVO embryos (Fig. 6F) .
As dysregulated GSH/GPx systems are highly associated with apoptotic regulation, it was not surprising that the apoptotic rates in IVF blastocysts were much higher than those in IVO blastocysts ( Fig. 6G and H) . In addition, qRT -PCR analysis also confirmed that some representative proapoptotic genes, which are responsible for mitochondria-mediated apoptosis, were significantly up-regulated in IVF blastocysts (Fig. 6I) .
Furthermore, based on the well-accepted role of melatonin in scavenging ROS and modulating mitochondrial functions, we explored the possibility that melatonin could compensate for the impaired GSH/GPx system and alleviate the enhanced apoptosis in IVF embryos. We observed that the GSH content was efficiently reversed in melatonintreated IVF embryos (Fig. 6E) , which was accompanied by decreased ROS levels (Fig. 6F) . As expected, apoptosis in IVF blastocysts was effectively reduced by melatonin supplementation (Fig. 6G and H) . Similarly, the expression of proapoptotic genes (Bak1, Bik, Bbc3 and Ddit3) was significantly inhibited by melatonin supplementation, suggesting a mechanism for melatonin's anti-apoptotic activity (Fig. 6I ).
Morphometric and phenotypic comparison of IVO and IVF embryos
At E7.5, well-developed IVO embryos at the gastrulation stage were characterized by a sealed-off amniotic cavity and the formation of three distinct cavities (amniotic cavity, exocoelom and ectoplacetal cleft). In contrast, the percentage of IVF embryos with delayed or abnormal morphologies was higher than the IVO groups. As reported by us recently, although IVF and IVO embryos have comparable implantation ability (78.60 versus 80.14%), both the survival rate (37.75 versus 46.80%) and embryonic weight (0.025 versus 0.029 g) of IVF embryos are lower than IVO embryos at this stage (Nie et al., 2013; Sui et al., 2014) . Blue dye injection of pregnant recipient mice at E6.5 and E7.5 revealed comparable implantation rates between IVO and IVF embryos. However, a substantial number of IVF embryos revealed overcrowded implantation sites and abnormal spacing, and greater variability in the size of the conceptuses (Fig. 7A) . A considerable proportion of IVF embryos at E7.5 showed delayed growth, or even severely disorganized or degenerating embryonic or extraembryonic tissues (Fig. 7B) , suggesting that growth defects first occur at about the time of implantation or very shortly thereafter. At E10.5 and E13.5, IVF embryos showed greater variability in size compared with IVO embryos (Fig. 7C and D) . IVF embryos showed various degrees of developmental delay, significant growth retardation or lethality from the pre-to post-implantation stage. In addition, we observed some IVF embryos with delayed or aberrant early neural development, including neural grooves that were not fully formed at E7.5, abnormal neural tube closure at E10.5 and exencephalic malformation (open brain) (Fig. 7B -D) . These observations from early-to mid-gestational stage were highly concordant with phenotype annotations of DEMGs that are functionally associated with fatty acid metabolism, amino acid metabolism, OXPHOS and transmembrane transport (Fig. 7E) .
Discussion
Highlighting mitochondria-related genes, this study compared the dynamic gene expression profiles of IVO and IVF embryos from the pre-to post-implantation stage. We found various aspects of mitochondrial function were altered in IVF embryos compared with IVO embryos, including: (i) inhibited mtDNA replication and mitochondrial biogenesis, which may cause a bottleneck during early embryogenesis; (ii) a consistently dysregulated GSH/GPx system, which leads to an aberrant response to ROS and disrupts the regulation of apoptosis; (iii) disturbed b-oxidation, OXPHOS and amino acid metabolism, which may lead to delayed embryonic development and impaired early neurogenesis; and (iv) disorganized mitochondrial transmembrane transport, which may impair overall mitochondrial function.
First, we showed that mtDNA copy number was reduced within IVF post-implantation embryos, which suggests mtDNA replication was depressed. Ssbp1 and Polg2 are the best known factors responsible for mtDNA replication (Ruhanen et al., 2010; Humble et al., 2013) . This is extremely important for post-implantation embryogenesis (Wai et al., 2010; Carling et al., 2011) . MGI annotations show that both Ssbp1 and Polg2 were annotated with 'embryonic lethality', implying that Polg2 and Ssbp1 inhibition contributes to impaired IVF embryonic development. Defects of mtDNA replication are accompanied with impaired mitochondrial biogenesis (Wan et al., 2012) . Many DEMGs observed in this study involved in the 'regulation of system process' are responsible for mitochondrial biogenesis. For example, altered Drd2 distribution can reduce mitochondrial number during neuropsychiatric disease (Fitzgerald et al., 2012) ; Adrb2 signaling can regulate skeletal muscle mitochondrial biogenesis (Robinson et al., 2011) ; nitric oxide generated by Nos can trigger mitochondrial biogenesis in many cell types (Nisoli et al., 2003; Nisoli and Carruba, 2006) ; and Leptin may promote mitochondrial biogenesis (Minokoshi et al., 2002; Li et al., 2011) . As a consequence of their role in mitochondrial biogenesis, and the fact that these genes were mainly annotated with 'decreased body weight' and 'decreased body size' phenotypes, the down-regulation of these genes may inhibit mitochondrial biogenesis during the post-implantation stage, and thereby impair the development of IVF embryos.
GO analysis also indicated disorganized mitochondrial protein synthesis during the post-implantation stage. Previous studies demonstrated that MRPs, a subcategory of ribosomal proteins encoded by nuclear genes, are translated on cytoplasmic ribosomes. These MRPs are then imported into the mitochondrial matrix, where they assemble with the two ribosomal RNAs (rRNAs) to form mitochondrial ribosomes. Mitochondrial ribosomes are exclusively responsible for the synthesis of the 13 mtDNA-encoded proteins required for mitochondrial biogenesis (Sylvester et al., 2004; Battersby and Richter, 2013) .
As melatonin was previously shown to improve mitochondrial functions by increasing mtDNA content and promoting mitochondrial biogenesis (Guo et al., 2014) , we hypothesized that melatonin treatment may rescue the depressed mtDNA replication and mitochondrial biogenesis in IVF embryos. We showed that treatment of IVF preimplantation embryos with melatonin at 10 29 M could alleviate depressed mtDNA replication during the post-implantation stage. Two key genes, Polg2 and Ssbp1, are likely involved in the melatonininduced increase in mtDNA copy number. This partially explains the previous observation that melatonin significantly increase the implantation rate of IVF mouse embryos . We also found that Dnmt1, which maintains global DNA methylation, was consistently down-regulated during the post-implantation stage. Recent studies confirm that DNMT1 can also translocate to the mitochondrial matrix to maintain mtDNA methylation (Shock et al., 2011; Bellizzi et al., 2013; Hong et al., 2013) . Indeed, deletion of Dnmt1 in mice was previously shown to cause genome-wide hypomethylation and embryonic lethality (Li et al., 1993; Biniszkiewicz et al., 2002) . Similarly, hypomethylation of imprinted genes in mice (Mann et al., 2004) , humans (Katari et al., 2009) and bovine (Chen et al., 2013) have been observed with IVF. Hypomethylation of imprinted genes is thought to be associated with increased frequency of Angelman syndrome and Beckwith-Weidemann syndrome in IVF children (Maher, 2005; Chiba et al., 2013) , and may cause large offspring syndrome in bovine (Hori et al., 2010; Chen et al., 2013) . More recently, reduced expression of DNMT1 in IVF sheep placentas was shown to be associated with defective imprinting of H19 and post-implantation mortality of IVF embryos (Ptak et al., 2013) . As we found that Dnmt1 was down-regulated in IVF embryos during the post-implantation stage, we hypothesized that the maintenance of DNA methylation of mitochondria-related genes was also impaired in IVF embryos.
We confirmed that both nDNA-encoded and mtDNA-encoded mitochondrial genes showed relative hypomethylation during the postimplantation stage. Moreover, there was evidence for a negative correlation between methylation status and expression levels of mitochondria-related genes. These results suggest that IVF processes could lead to changes in epigenetic modifications of both nDNA-encoded and mtDNAencoded mitochondrial genes, which causes further mitochondrial dysfunction. To the best of our knowledge, our study is the first to show disrupted methylation of a specific mtDNA-encoded mitochondrial gene in IVF embryos. MT-ND2 encodes the core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), which is the largest enzyme of the respiratory chain complexes. MT-ND2 is extremely crucial for Complex I functioning in the transfer of electrons from NADH to the respiratory chain (Papa et al., 2012) . MT-ND2 mutations, which impair mitochondrial Complex I assembly and lead to a significant reduction in Complex I activity (Ugalde et al., 2007) , are thought to be linked to the cause of a number of NDs and cancers (Lin et al., 1992; Schnopp et al., 1996) . In addition, Complex I is a major source of ROS in mitochondria and a significant contributor to cellular oxidative stress (Kussmaul and Hirst, 2006) . This is thought to explain why its dysfunction is associated with various neurodegenerative and inflammatory diseases and cancers (Wiseman and Halliwell, 1996; Lin and Beal, 2006) . Given that DNA methylation can stably alter the expression of genes (Jaenisch and Bird, 2003) , aberrant methylation may cause long-term dysregulated expression of MT-ND2, and thereafter disrupt the structure and/or function of Complex I. This mechanism may not only impair the development of IVF embryos, but also predispose IVF offspring to potentially increased risks of a number of diseases. It is unclear why IVF embryos show a MT-ND2-specific hypomethylation in mtDNA. While the IVF-induced selective loss of imprinting or hypomethylation in specific regions has also been demonstrated for nDNA (Mann et al., 2004) , little is known about the underlying mechanism. However, some undefined sequence or structure characteristics may affect the accessibility of DNMTs to the specific region, which could explain the variable susceptibility of different regions to epigenetic errors.
Second, we found that IVF embryos had a dysregulated GSH/GPx system, which is essential for protecting mammalian cells against oxidative stress (Li et al., 2000; Tanaka et al., 2002) . GSH is the most abundant antioxidant and is a major detoxification agent in cells (Circu and Aw, 2012) . The two key genes responsible for GSH synthesis, Gclc and Glul, were consistently down-regulated from E3.5 to E10.5. GSH content was dramatically decreased in IVF blastocysts. Considering that GSH synthesis is critical for embryonic development during implantation (Shi et al., 2000; Fu et al., 2014) , this reduction may make a significant contribution to impaired IVF embryo. On the other hand, GPX4, a free radical scavenging enzyme that oxidizes GSH to GSSG (Ufer and Wang, 2011) , was consistently up-regulated in IVF embryos. Gpx4 can be detected in most subcellular compartments, including mitochondria, where it may modulate redox-dependent cellular responses (Arai et al., 1999; Handy et al., 2009) . Well-regulated expression of Gpx is thought to be highly associated with embryonic developmental potential (Ufer and Wang, 2011) .
As previous studies suggest oxidative stress can activate GPX4 (Duval et al., 2002; King et al., 2010; Maseko et al., 2014) , we hypothesized that Gpx4 expression was activated under in vitro conditions, to scavenge excessive ROS. ROS generation has been implicated as a major cause of the lower developmental rate of IVF embryos (Dalvit et al., 2005) . Indeed, embryo in vitro culture produces higher oxygen concentrations than in vivo environments, resulting in increased ROS production (Luvoni et al., 1996) . Our GO analysis showed that IVF embryos underwent a depressed 'response to ROS' from the pre-to post-implantation stage. However, in the subcategory of 'response to ROS', the DNAdamage inducible transcript 3 (Ddit3) was up-regulated in IVF embryos. Ddit3 is a proapoptotic gene, and is thought to mediate ROS-induced apoptosis . Correspondingly, many terms, such as 'regulation of programmed cell death' and 'apoptosis', were enriched at the three time points. This implies that mitochondriamediated apoptosis regulation is consistently disrupted from the pre-to post-implantation stage.
Previous studies demonstrated that the incidence of apoptosis in preimplantation embryos was negatively associated with implantation and developmental potential during the post-implantation stage (Loureiro et al., 2007; Chang et al., 2012) . This is in accordance with the observation in our published study that IVF embryos had a lower implantation rate and survival rate (Sui et al., 2014) . Correspondingly, our MGI analysis indicated that some genes involved in mitochondria-mediated apoptosis were annotated with phenotypes such as 'decreased embryo size', 'partial prenatal lethality' and 'embryonic growth arrest'. Our analysis of apoptosis in the preimplantation embryos confirmed that IVF processes induced an increased level of apoptosis. However, this is the first report that IVF processes cannot only result in high levels of ROS, but also impair the glutathione antioxidant system, which in turn, leads to increased apoptosis.
Interestingly, mitochondria are both a major source and target of ROS (Simon et al., 2000) . Mitochondria also play key roles in activating apoptosis in mammalian cells (Wang and Youle, 2009 ). Mitochondria-ROS crosstalk is crucial for apoptosis induction under both physiological and pathological conditions (Ling et al., 2003; Malik et al., 2007; Marchi et al., 2012) . Previous studies (Ishizuka et al., 2000; Abecia et al., 2002; Shi et al., 2009; Wang et al., 2013) and our recently published work (Tan et al., 2015) indicate that melatonin can improve in vitro embryonic development. In this study, supplementation of melatonin in the culture medium restored the GSH concentration and reduced ROS levels in IVF embryos. More importantly, the expression patterns of several key genes responsible for mitochondria-mediated apoptosis were significantly reversed by melatonin supplementation. Melatonin can modulate the expression of proapoptotic Bcl-2 family members (Radogna et al., 2008; Mohseni et al., 2012; Bekyarova et al., 2013) , and has previously been shown to prevent the pathology of NDs by mitigating ROS-induced mitochondrial malfunction (Leon et al., 2004 (Leon et al., , 2005 Dragicevic et al., 2011; Srinivasan et al., 2011) . Therefore, we hypothesize that melatonin could potentially alleviate apoptosis of IVF preimplantation embryos.
Third, we showed that oxoacid metabolism, oxidative phosphorylation (OXPHOS) and amino acid metabolism were altered in IVF embryos. Preimplantation embryos typically generate adenosine triphosphate (ATP) mainly through OXPHOS and glycolysis (Guerin et al., 2001) . However, both of these ATP-generation pathways were disturbed in IVF preimplantation embryos. We hypothesized that enhanced fatty acid b-oxidation in mitochondria may compensate for the compromised energy supply of IVF embryos. Indeed, at E3.5, we found that many enzymes responsible for mitochondrial fatty acid b-oxidation were up-regulated in IVF blastocysts, including acyl-CoA synthetase long-chain family member 5 (Acsl5), Acsl6, acyl-CoA thioesterase 7 (Acot7) and malonyl-CoA decarboxylase (Mlycd). Carnitine palmitoyltransferase 1b (Cpt1b) and Cpt1c, which are responsible for the rate-limiting step of b-oxidation (Dunning et al., 2010) , were especially up-regulated in IVF embryos at E3.5.
While less attention has been paid to lipid metabolism compared with carbohydrate metabolism during early embryonic development, oocytedeposited lipids are thought to be essential for preimplantation embryonic development in many species (McEvoy et al., 2000) . In addition, the contribution of fatty acids as an energy source to oocyte developmental competence and early embryo development has been demonstrated in bovines (Ferguson and Leese, 2006) and mice (Hewitson et al., 1996) . Aberrant mitochondrial lipid metabolism in our IVF embryos was also reflected in reduced prostaglandin synthesis, which in turn, could cause mitochondrial dysfunction (Yoda et al., 2010) . That is, as indicated by GO analysis and the PPI network, genes involved in prostaglandin synthesis, such as prostaglandin-endoperoxide synthase 1 (Ptgs1) and arachidonate 5-lipoxygenase (Alox5) and fatty acid elongation 3-oxoacyl-ACP synthase, mitochondrial (Oxsm) and ELOVL family member 6, elongation of long-chain fatty acids (Elovl6), were down-regulated at E7.5.
KEGG pathway analysis also showed that during the post-implantation period in IVF embryos, the expression of genes involved in steroid hormone biosynthesis, including catechol-O-methyltransferase (Comt), hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid deltaisomerase 6 (Hsd3b6), steroidogenic acute regulatory protein (Star), cytochrome P450, family 17, subfamily a, polypeptide (Cyp17a1, Cyp3a13, Cyp11a1), was aberrant. Mitochondria are essential sites of steroid hormones biosynthesis (Miller, 2013) . Steroid hormones regulate embryonic metabolism (Lauria et al., 1979) , and are critical for embryo implantation (Cheng et al., 2002) . The access of cholesterol to mitochondria is the rate-limiting step for steroidogenesis, which is achieved by the steroidogenic acute regulatory protein (Star) (Miller, 2013) . Both Star and the StAR-related lipid transfer domain containing 13 (Stard13) were annotated with phenotypes of 'decreased body size' and 'decreased body weight'. Therefore, mitochondrial steroid hormones biosynthesis may be a determinant for impaired embryonic development, or even for the delayed post-natal growth, after IVF processes.
From E3.5 to E10.5, the pathways of NDs, including AD, PD and HD, were consistently presented. Detailed analysis of enriched DEMGs showed that the genes involved were mainly responsible for OXPHOS and the electron transport chain. Despite the differential clinical features of the various NDs, the fact that neurons are highly dependent on oxidative energy metabolism suggests a unified pathogenesis (Schon and Manfredi, 2003) . The MGI analysis also indicated many DEMGs were annotated with phenotypes such as 'neurodegeneration', 'decreased neuron number', 'decreased neuronal precursor cell number' and 'increased neuron apoptosis'. Among these genes, special attention should be paid to the consistently dysregulated DEMGs, including ATPase, Cu 2+ transporting, alpha polypeptide (Atp7a) and acyl-CoA thioesterase 7 (Acot7). NDs pathways were consistently enriched from the pre-to postimplantation period, which is critical for initiation of neural development (Brumwell and Curran, 2006 ). In addition, many genes involved in neurodevelopment were consistently dysregulated in the IVF embryos. Therefore, mitochondrial dysfunction may lead to neural disorders in children and predispose IVF offspring to a potentially increased risk of NDs in adulthood, based on the 'fetal origins of adult disease' hypothesis proposed by Barker (Barker et al., 2002) . This hypothesis may correlate with randomly observed phenotypes, for example, the insufficient neural tube closure in E10.5 and E13.5 embryos.
During early embryonic development, IVF embryos also showed a consistent aberration in amino acid metabolism. Mitochondria play a central role in amino acid homeostasis, not only by producing energy using amino acids as substrate, but also by providing precursors for de novo synthesis of amino acids (Johnson et al., 2014) . Based on the KEGG analysis, metabolism of many amino acids, including arginine, aspartic acid, proline and glutamine, were consistently disrupted during early embryonic development. In addition, many mitochondrial enzymes responsible for the urea cycle were dysregulated, including liver arginase (Arg1), agmatinase (Agmat), carbamoyl-phosphate synthetase 1 (Cps1) and glutaminase (Gls). The urea cycle, which is the principal biochemical pathway responsible for converting ammonia to the less toxic chemical, urea, begins in mitochondria. Dysregulation of the urea cycle may lead to an accumulation of nitrogenous waste, mainly ammonia, which has an adverse effect on embryonic development (Watanabe, 1997; Hammon et al., 2000) .
Many genes involved in arginine metabolism were also inhibited during the peri-implantation period, such as argininosuccinate synthetase 1 (Ass1), aldehyde dehydrogenase 18 family, member A1 (Aldh18a1), Arg1, Nos1 and Cps1. Arginine is crucial for embryo implantation during early pregnancy (Zeng et al., 2008 , and deficient arginine consumption is thought to be highly associated with intrauterine growth restriction (Greenberg et al., 1997; Brown et al., 2011) . Arginine is also the precursor of endogenous nitric oxide, a well-documented mitochondrial biogenesis trigger (Nisoli et al., 2003; Nisoli and Carruba, 2006) . The MGI analysis also indicated that these genes were involved in 'decreased body size' and 'decreased body weight' phenotypes. Therefore, mitochondrial-induced aberrations in amino metabolism are likely to impair in vitro embryonic development.
Fourth, IVF embryos showed consistently disorganized mitochondrial transmembrane transport compared with IVO embryos. At the three time points, 'transmembrane transport' and 'intracellular transport' were consistently presented. Many members/components of families/ complex responsible for transmembrane transport were dysregulated in IVF embryos, including the solute carrier family, ATP-binding cassette (ABC) transporters, mitochondrial ATP synthase and translocase of inner mitochondrial membrane. The carrier proteins that were disrupted at E3.5 included the solute carrier protein family 25, member 22 (Slc25a22), Slc25a13, Slc25a47, Slc25a24, Slc25a45, Slc25a31, Slc22a4 and Slc35b3. At E7.5, the proteins included Slc25a13, Slc25a36, Slc25a19, Slc25a24, Slc12a2, Slc22a4 and Slc25a25; and at E10.5, they included Slc25a14, Slc25a31 and Slc25a18. Most belonged to the solute carrier family 25 subfamily, which is specifically responsible for solute transport across the mitochondrial membrane (Palmieri, 2004) . Among these genes, Slc25a22, Slc25a13 and Slc25a18 are mainly responsible for glutamate and/or aspartate transport. The transport of glutamate and aspartate is crucial for the urea cycle; therefore, down-regulation of these genes may contribute significantly to the aberrant amino acid metabolism. This agreed with results of the MGI analysis, in which Slc25a13 was annotated with 'abnormal amino acid level' and 'decreased body weight'.
Other DEMGs involved in transmembrane transport are the ABC transporters, including: ABC subfamily C, member 12 (Abcc12), Abcb1b, Abcb4 at E3.5; Abcc12, Abca8b, Abca1, Abcd2 at E7.5 and Abcb1a, Abca12 at E10.5. ABC transporters translocate a wide variety of substrates, including metabolic products, lipids and sterols (Davidson et al., 2008) . As mammalian mitochondrial ABC transporters can help prevent mitochondrial dysfunction caused by increased ROS generation (Liesa et al., 2012) , down-regulation of these genes may affect embryonic development. We also noted that cystic fibrosis transmembrane conductance regulator (Cftr), which encodes an ABC transporter-class ion channel, was downregulated at E10.5. Previous studies indicated that Cftr is crucial for ion transport in preimplantation embryos (Ben-Chetrit et al., 2002) and its disruption would lead to impaired embryo implantation .
Some genes specifically responsible for the mitochondrial ion transport were dysregulated in IVF embryos, including: uncoupling protein 2 (Ucp2) at E3.5; calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), Cacna1b, ATPase, Cu 2+ transporting, beta polypeptide (Atp7b) at E7.5; ATP synthase, H + transporting, mitochondrial F0 complex, subunit F2 (Atp5j2), Atp5l, Atp5e, Atp5g1, Atp7a at E10.5. UCP2 belongs to the family of mitochondrial anion carrier proteins, and transfers protons from the outer to the inner mitochondrial membrane. This uncouples oxidative phosphorylation from ATP synthesis. UCP2 is reported to be a key protein involved in the oxidation of fatty acids, glutamine and glucose. It does so by controlling substrate exchange between the cytoplasm and the mitochondrial matrix. It is thought that UCP2 can augment fatty acid or glutamine oxidation and decreases glucose-derived pyruvate oxidation in mitochondria by blocking the entry of pyruvate into the TCA cycle (Emre and Nubel, 2010; Zhang et al., 2011) . It also appears that UCP2 plays an essential role in controlling mitochondria-derived ROS (Arsenijevic et al., 2000) . Atp5e, Atp5j2, Atp5l and Atp5g1 encode the catalytic core and membrane-spanning components of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis by means of an electrochemical gradient of protons across the inner membrane during OXPHOS, and thereby affect embryonic development. Indeed, a homozygous mutant of Atp5l induced a complete embryonic lethality during gestation, while the heterozygous mutant led to a decreased body weight after birth (Baran et al., 2007; Gardin and White, 2011) . Based on GO analysis, we also found that some genes involved in the mitochondrial membrane organization were down-regulated in IVF embryos. For example, Metaxin 1 (Mtx1), a component of a protein import complex in the outer membrane of the mammalian mitochondria, was down-regulated. Mtx1 deficiency can alter the mitochondrial membrane permeability (Ono et al., 2010) , and is essential for embryonic development in mice (Bornstein et al., 1995) . In addition, spastin (Spast) was down-regulated; mutant Spast has previously been associated with an abnormal cytoplasmic clustering of mitochondria (McDermott et al., 2003; Lumb et al., 2012) . Similarly, Spast was shown to be critical for promoting axonal outgrowth during embryonic development in zebrafish (Wood et al., 2006) . This is in accordance with our MGI analysis, in which Spast was annotated with 'abnormal axon morphology'. Optic atrophy 1 (Opa1) was also down-regulated in IVF embryos. Opa1 is a mitochondrial protein with similarity to dynamin-related GTPases, and could promote neuronal survival, by impairing mitochondrial remolding or sustaining mitochondrial morphology (Davies et al., 2007; Jahani-Asl et al., 2011; Ramonet et al., 2013) . Therefore, our IVF embryos showed a down-regulation of a number of proteins involved in mitochondrial transmembrane transport. This may impair overall mitochondrial function, leading to impaired development of IVF embryos.
This study has some limitations, including the fact that our findings in the mouse embryo and fetus may not be fully transferable to humans. In addition, while some previous studies have demonstrated that oral uptake (Eryilmaz et al., 2011; Fernando et al., 2014) and direct culture medium supplementation (Kim et al., 2013) of melatonin has significant beneficial effects on IVF outcomes, other health risks may be associated with supplementation. In the future, the effect of melatonin supplementation on the long-term health of IVF babies, and the clinical application of modified IVF culture medium, should be fully evaluated based on a series of animal experiments and large-population clinical studies.
Conclusion
In summary, this study showed that many mitochondria-related biological processes are consistently dysregulated in IVF early embryos. These effects could be significantly associated with compromised development of IVF embryos, and may predispose IVF offspring to an increased risk of diseases. More importantly, we identified that the mitochondriatargeted antioxidant melatonin could significantly alleviate inhibited mtDNA replication, as well as dysregulated GSH homeostasis and ROS-induced apoptosis. These novel observations provide us a new insight in understanding the mechanism of IVF-induced aberrant embryonic development, and provide a promising strategy for improving existing IVF systems by modulating mitochondrial functions.
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